open access
Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy
, 1, 2, 1
Affiliations- Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine — National Research Institute, Warsaw, Poland
- Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
thyroid cancer; sleeve gastrectomy; liquid levothyroxine
About this articleTitle
Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy
Journal
Issue
Article type
Clinical vignette
Pages
439-440
Published online
2023-07-18
Page views
742
Article views/downloads
257
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2023;74(4):439-440.
Keywords
thyroid cancer
sleeve gastrectomy
liquid levothyroxine
Authors
Adam Daniel Durma
Marek Saracyn
Anna Celina Durma
Grzegorz Kamiński
References (5)- Miccoli P, Materazzi G, Rossi L. Levothyroxine Therapy in Thyrodectomized Patients. Front Endocrinol (Lausanne). 2020; 11: 626268.
- Jarząb B, Dedecjus M, Lewiński A, et al. Diagnosis and treatment of thyroid cancer in adult patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]. Endokrynol Pol. 2022; 73(2): 173–300.
- Chacon D, Bernardino T, Geraghty F, et al. Bariatric Surgery With Roux-En-Y Gastric Bypass or Sleeve Gastrectomy for Treatment of Obesity and Comorbidities: Current Evidence and Practice. Cureus. 2022; 14(6): e25762.
- Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kudła B, et al. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy]. Endokrynol Pol. 2020; 71(5): 441–465.
- Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12): 631–636.
